BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24851923)

  • 1. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.
    Perucci LO; Gomes KB; Freitas LG; Godoi LC; Alpoim PN; Pinheiro MB; Miranda AS; Teixeira AL; Dusse LM; Sousa LP
    PLoS One; 2014; 9(5):e97632. PubMed ID: 24851923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
    Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
    Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling.
    Wang Y; Chen Q; Zhao M; Walton K; Harrison C; Nie G
    J Clin Endocrinol Metab; 2017 Aug; 102(8):3065-3074. PubMed ID: 28633389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
    Soto E; Romero R; Kusanovic JP; Ogge G; Hussein Y; Yeo L; Hassan SS; Kim CJ; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal circulating levels of transforming growth factor-β superfamily and its soluble receptors in hypertensive disorders of pregnancy.
    Xu YT; Shen MH; Jin AY; Li H; Zhu R
    Int J Gynaecol Obstet; 2017 Jun; 137(3):246-252. PubMed ID: 28281288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women.
    ElMonier AA; El-Boghdady NA; Abdelaziz MA; Shaheen AA
    Arch Biochem Biophys; 2019 Feb; 662():7-14. PubMed ID: 30496724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
    Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
    Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations.
    Chaiworapongsa T; Romero R; Kusanovic JP; Mittal P; Kim SK; Gotsch F; Than NG; Mazaki-Tovi S; Vaisbuch E; Erez O; Yeo L; Hassan SS; Sorokin Y
    Ultrasound Obstet Gynecol; 2010 Feb; 35(2):155-62. PubMed ID: 20101637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2014 Oct; 44(4):402-10. PubMed ID: 24913462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi--associations with placental malaria and fetal growth restriction.
    Silver KL; Conroy AL; Leke RG; Leke RJ; Gwanmesia P; Molyneux ME; Taylor DW; Rogerson SJ; Kain KC
    PLoS One; 2011; 6(9):e24985. PubMed ID: 21966395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of TGF-β1, cytokines, angiogenic, and anti-angiogenic factors in pregnant women who smoke.
    Schubert CL; Yusuf K
    J Reprod Immunol; 2021 Sep; 147():103351. PubMed ID: 34293588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.